Targeting mitochondrial 18 kDa translocator protein (TSPO) regulates macrophage cholesterol efflux and lipid phenotype

Clinical Science

Volumn 127, Issue 10, 2014, Pages 603-613

  Taylor, Janice M W ^a   Allen, Anne Marie ^a   Graham, Annette ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

(apo)lipoprotein A I (apoa I); High density lipoprotein (HDL); Macrophage foam cell; Mitochondrial cholesterol trafficking; Translocator protein (TSPO)

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G4; ACETYL LOW DENSITY LIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CARRIER PROTEIN; FLUNITRAZEPAM; FORMAZAN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR ALPHA; MITOCHONDRIAL PROTEIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; STAT3 PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSLOCATOR PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ADULT; ARTICLE; CAROTID ATHEROSCLEROSIS; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; FOAM CELL; GENE SILENCING; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPOGENESIS; MACROPHAGE; MACROPHAGE CHOLESTEROL EFFLUX; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING;

ADULT; ANIMALS; APOLIPOPROTEIN A-I; ATP BINDING CASSETTE TRANSPORTER 1; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CHOLESTEROL; FEMALE; FOAM CELLS; GENE EXPRESSION; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MIDDLE AGED; MITOCHONDRIA; PHENOTYPE; PPAR ALPHA; RECEPTORS, GABA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84905668746     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20140047     Document Type: Article

References (44)

1. Madamanchi, N. R. and Runge, M. S. (2007) Mitochondrial dysfunction in atherosclerosis. Circ. Res. 100, 460-473
2. Zoltan, U., Sonntag, W. E. and Csiszar, A. (2010) Mitochondria and aging in the vascular system. J. Mol. Med. 88, 1021-1027
3. Puddu, P., Puddu, G. M., Carvero, E., De Pascalis, S. and Muscari, A. (2009) The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis. J. Biomed. Sci. 16, 112
4. Mercer, J. R., Cheng, K.-K., Figg, N., Gorenne, I., Mahmoudi, M., Griffin, J., Vidal-Puig, A., Logan, A., Murphy, N. P. and Bennett, M. (2010) DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ. Res. 107, 1021-1031
5. Gerrity, R. G. (1981) The role of the monocyte in atherogenesis. Am. J. Pathol. 103, 181-190
6. Kannel, W. M. (1983) High density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am. J. Cardiol. 52, 9B-12B
7. Taylor, J. M. W., Borthwick, F., Bartholomew, C. and Graham, A. (2010) Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI. Cardiovasc. Res. 86, 526-534
8. Ning, Y., Bai, Q., Lu, H., Li, X., Pandak, W. M., Zhao, F., Chen, S., Ren, S. and Yin, L. (2009) Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages. Atherosclerosis 204, 114-120
9. Ning, Y., Xu, L., Ren, S., Pandak, W. M., Chen, S. and Yin, L. (2009) StAR overexpression decreases serum and tissue lipids in apolipoprotein E-deficient mice. Lipids 44, 511-519
10. Pandak, W. M., Ren, S., Marques, D., Hall, E., Redford, K., Mallonnee, D., Bohdan, P., Heuman, D., Gil, G. and Hylemon, P. (2002) Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes. J. Biol. Chem. 277, 48158-49164
11. Ren, S., Hyelmon, P., Marques, D., Hall, E., Redford, K., Gil, G. and Pandak, W. M. (2004) Effect of increasing the expression of cholesterol transporters (StAR, MLN64 and SCP-2) on bile acid synthesis. J. Lipid Res. 45, 2123-2131
12. Venkateswaran, A., Lafitte, B. A., Joseph, M. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A. and Tontonez, P. (2000) Control of cellular cholesterol efflux by the nuclear oxysterol receptor, LXR alpha. Proc. Natl. Acad. Sci. U.S.A. 97, 12097-12102
13. Oram, J. F. and Heinecke, J. W. (2005) ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol. Rev. 85, 1343-1372
14. Wang, N., Lan, D., Chen, W., Matsuura, F. and Tall, A. R. (2004) ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 101, 9774-9779
15. Gallus, G. N., Dotti, M. T. and Federico, A. (2006) Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol. Sci. 27, 143-149
16. Rone, M. B., Fan, J. and Papadopoulos, V. (2009) Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim. Biophys. Acta 1791, 646-658
17. Batarseh, A. and Papadopoulos, V. (2010) Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states. Mol. Cell Endocrinol. 327, 1-12
18. Lecanu, L., Yao, Z. X., McCourty, A., Sidahmed, E.-K., Orellana, M. E., Burnier, M. N. and Papadopoulos, V. (2012) Control of hypercholesterolaemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO. Steroids 78, 137-146
19. Gut, P., Baeza-Raja, B., Andersson, O., Hasenkamp, L., Hsiao, J., Hesselson, D., Akassoglou, K., Verdin, E., Hirschey, M. D. and Stainier, D. Y. R. (2012) Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism. Nat. Chem. Biol. 9, 97-104
20. Brown, M. S., Basu, S. K., Falck, J. R., Ho, Y. K. and Goldstein, J. L. (1980) The scavenger receptor pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively charged LDL by macrophages. J. Supramol. Struct. 13, 67-81
21. Schnoor, M., Buyers, I., Sietmann, A., Brodde, M. F., Hofnagel, O., Robenek, H. and Lorkowski, S. (2009) Efficient non-viral transfection of THP-1 cells. J. Immunol. Methods 344, 109-115
22. Borthwick, F., Taylor, J. M., Bartholomew, C. and Graham, A. (2009) Differential regulation of the STARD1 subfamily of START lipid trafficking proteins in human (THP-1) macrophages. FEBS Lett. 583, 1147-1153
23. Borthwick, F., Allen, A. M., Taylor, J. M. and Graham, A. (2010) Over-expression of STARD3 in human monocyte-macrophages induces an anti-atherogenic lipid phenotype. Clin. Sci. 119, 265-272
24. Rae, C., Robertson, S., Taylor, J. M. and Graham, A. (2007) Resistin induces lipolysis and re-esterification of triacylglycerol stores, and increases cholesteryl ester deposition, in human macrophages. FEBS Lett. 581, 4877-4883
25. Rosenson-Schloss, R. S., Chnari, E., Brieva, T. A., Dang, A. and Moghe, P. V. (2005) Glutathione preconditioning attenuates AcLDL-induced macrophage apoptosis via protein kinase C-dependent AcLDL trafficking. Exp. Biol. Med. 230, 40-48
26. Xu, H. E., Stanley, T. B., Montana, V. G., Lambert, M. H., Shearer, B. G., Cobb, J. E., McKee, D. D., Galardi, C. M., Plunket, K. D., Nolte, R. T. et al. (2002) Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα. Nature 415, 813-817
27. Farke, C., Meyer, H. H., Bruckmaier, R. M. and Albrecht, C. (2008) Differential expression of ABC transporters and their regulatory genes during lactating and dry period in bovine mammary tissue. J. Dairy Res. 75, 406-414
28. Feramisco, J. D., Goldstein, J. L. and Brown, M. S. (2004) Membrane topology of human Insig-1, a protein regulator of lipid synthesis. J. Biol. Chem. 279, 8487-8496
29. Zeng, L., Liao, H., Liu, Y., Lee, T. S., Zhu, M., Wang, X., Stemerman, M. B., Zhu, Y. and Shyy, J. Y. (2004) Sterol responsive element-binding protein (SREBP)2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J. Biol. Chem. 279, 48801-48807
30. Fernandez-Hernando, C. and Moore, K. J. (2011) MicroRNA modulation of cholesterol homeostasis. Arterioscler. Thromb. Vasc. Biol. 31, 2378-2382
31. Engel, T., Lorkowski, S., Lueken, A., Rust, S., Schluter, B., Berger, G., Cullen, P. and Assman, G. (2001) The human ABCG4 gene is regulated by oxysterols and retinoids in monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 288, 483-488
32. Rigamonti, E., Chinetti-Gbaguidi, G. and Staels, B. (2008) Regulation of macrophage functions by PPARα, PPARγ and LXRs in mice and men. Arterioscler. Thromb. Vasc. Biol. 28, 1050-1059
33. Pyper, S. R., Viswakarma, N., Yu, S. and Reddy, J. K. (2010) PPARα: energy combustion, hypolipidaemia, inflammation and cancer. Nucl. Recept. Signal. 8, e002
34. Ogata, M., Tsujita, M., Hossain, M. A., Akita, N., Gonzalez, F. J., Staels, B., Suzuki, S., Fukutomi, T., Kimura, G. and Yokoyama, S. (2009) On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis 205, 413-419
35. Hebbachi, A. M., Knight, B. L., Wiggins, D., Patel, D. D. and Gibbons, G. F. (2008) Peroxisome proliferator activated-receptorα deficiency abolishes the response of lipogenic gene expression by re-feeding: restoration of the normal response by activation of liver X receptor α. J. Biol. Chem. 283, 4866-4876
36. Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C. and Li, L. (2000) Role of LXRs in control of lipogenesis. Genes Dev. 14, 2831-2939
37. Bird, J. L., Izquierdo-Garcia, D., Davies, J. R., Rudd, J. H., Probst, K. C., Figg, N., Clark, J. C., Weissberg, P. L., Davenport, A. P. and Warburton, E. A. (2010) Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis 210, 388-391
38. Khan, J. A., Cao, M., Kang, B. Y., Liu, Y., Mehta, J. L. and Hermonat, P. L. (2010) AAV/STAT3-gene delivery lowers aortic inflammatory cell infiltration in LDLR KO mice on high cholesterol. Atherosclerosis 213, 59-66
39. Yelieev, A. A., Krueger, K. E. and Kaplan, S. (1997) A mammalian mitochondrial drug receptor functions as a bacterial 'oxygen' sensor. Proc. Natl. Acad. Sci. U.S.A. 94, 5101-5106
40. Zeng, X. and Kaplan, S. (2011) TspO as a modulator of the repressor/antirepressor (PpsR/AppA) regulatory system in Rhodobacter sphaeroides 2.4.1. J. Bacteriol. 183, 6355-6364
41. Vanhee, C. and Batoko, H. (2011) Arabidopsis TSPO and porphyrins metabolism: a transient signalling connection? Plant Signal. Behav. 6, 1383-1385
42. Dmitrova-Shumkovska, J., Veenan, L., Ristoski, T., Leschiner, S. and Gavish, M. (2010) Chronic high fat, high cholesterol supplementation decreases 18 kDa translocator protein binding capacity in association with increased oxidative stress in rat liver and aorta. Food Chem. Toxicol. 48, 910-921
43. Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schule, C., Northdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F. et al. (2009) Translocator protein (18 kDa) as target for anxiolytics without benzodiazepine-like side effects. Science 325, 490-493
44. Falchi, A. M., Batteta, B., Sanna, F., Piludu, M., Sogos, V., Serra, M., Melis, M., Puzolu, M. and Diaz, G. (2007) Intracellular cholesterol changes induced by translocator protein (18 kDa) TSPO/PBR ligands. Neuropharmacology 53, 318-329